Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06585969 | A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer(DISCORDANT) | withdrawn | Phase 3 | 0 | Danish Breast Cancer Cooperative GroupOTHER | 0 | Feb 12, 2026 | clinicaltrials |
| NCT07092475 | The Impact of Intraoperative Methadone on Postoperative Opioid Use | withdrawn | Phase 3 | 0 | University of UtahOTHER | 1 | Nov 26, 2025 |
| clinicaltrials |
| NCT02883361 | Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors(MI for AIs) | withdrawn | Phase 2 / Phase 3 | 0 | University of CalgaryOTHER | 1 | Dec 5, 2024 | clinicaltrials |
| NCT05474690 | A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer | withdrawn | Phase 3 | 0 | Henan Cancer HospitalOTHER_GOV | 1 | Feb 26, 2024 | clinicaltrials |
| NCT03658213 | To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.(LARES) | withdrawn | Phase 3 | 0 | AstraZenecaINDUSTRY | 1 | May 10, 2021 | clinicaltrials |
| NCT04281355 | Individualized Locoregional Treatment of Initially Biopsy-proven Node-positive Breast Cancer After Primary Systemic Therapy(INDAX) | withdrawn | Phase 3 | 0 | Karolinska InstitutetOTHER | 0 | Feb 25, 2021 | clinicaltrials |
| NCT00397761 | Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Medstar Health Research InstituteOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT03811418 | A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer(ATTILA) | withdrawn | Phase 3 | 0 | iOMEDICO AGINDUSTRY | 1 | Nov 26, 2019 | clinicaltrials |
| NCT01796444 | Axillary Lymph Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node(Z0011-China) | withdrawn | Phase 3 | 0 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT02269696 | The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer Patients | withdrawn | Phase 3 | 0 | Kuopio University HospitalOTHER | 0 | Mar 22, 2018 | clinicaltrials |
| NCT03081234 | Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast Cancer(EarLEE-2) | withdrawn | Phase 3 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Mar 15, 2018 | clinicaltrials |
| NCT02784730 | Iterative PICC Placement Versus Long Term Device(PICC One Day) | withdrawn | Phase 3 | 0 | Centre Leon BerardOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT01724242 | Vaginal DHEA for Women After Breast Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Hadassah Medical OrganizationOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT02768714 | Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy | withdrawn | Phase 3 | 0 | Eurofarma Laboratorios S.A.INDUSTRY | 0 | Sep 15, 2017 | clinicaltrials |
| NCT02651610 | Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Peregrine PharmaceuticalsINDUSTRY | 1 | Jul 11, 2017 | clinicaltrials |
| NCT00695916 | MRI in Women With Newly Diagnosed Breast Cancer Prior to Breast Conserving Surgery | withdrawn | Phase 3 | 0 | Stanford UniversityOTHER | 0 | Feb 1, 2017 | clinicaltrials |
| NCT00692458 | A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029) | withdrawn | Phase 3 | 0 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 12, 2016 | clinicaltrials |
| NCT00041171 | Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT00053339 | Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT02539615 | A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old | withdrawn | Phase 3 | 0 | Atossa Therapeutics, Inc.INDUSTRY | 1 | Jan 25, 2016 | clinicaltrials |
| NCT00301886 | S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone | withdrawn | Phase 3 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 13, 2013 | clinicaltrials |
| NCT00324714 | Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS | withdrawn | Phase 3 | 0 | ETOP IBCSG Partners FoundationNETWORK | 1 | Nov 29, 2012 | clinicaltrials |
| NCT00403182 | Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer | withdrawn | Phase 3 | 0 | Technical University of MunichOTHER | 1 | Jun 1, 2012 | clinicaltrials |
| NCT00942396 | Study to Compare the Diagnostic Accuracy of Nuance Full-Field Digital Mammography to Screen-Film Mammography | withdrawn | Phase 3 | 250 | Planmed OyINDUSTRY | 1 | Jun 9, 2011 | clinicaltrials |
| NCT00888082 | Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy(PROOF) | withdrawn | Phase 3 | 102 | AstraZenecaINDUSTRY | 1 | Dec 10, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Feb 12, 2026source: clinicaltrials